Stroke Prevention in Symptomatic Large Artery Intracranial Atherosclerosis
Practice Advisory, March 2022
Read Published ArticleThis practice advisory reviews and explains the data supporting recommendations for medical management for reducing the risk of recurrent stroke or death in patients with symptomatic intracranial atherosclerotic arterial stenosis (s-ICAS). Antithrombotics, dyslipidemic agents, and lifestyle modification can all be effective management options. Stenting should not be recommended as the initial treatment for s-ICAS. Additional research is underway to determine the effectiveness of other management approaches, including other antithrombotics and endovascular/surgical techniques.
Endorsed by the American Heart Association/American Stroke Association, the Neurocritical Care Society, and the Society of Vascular and Interventional Neurology.
Reaffirmed on April 7, 2025.
Clinician Tools and Materials
Clinician Summary
Download a PDF summary of this guideline product
Full-length Version
Download a PDF of the full guideline product, including full details of the methodology and data analysis
Pocket Guideline Clinician Summary
Access a digital interactive summary of the recommendations and other key information from the guideline
好色先生al Materials
Other resources related to this guideline
Patient Tools and Materials
Patient Summary
Read a summary of the key messages of this guideline product for patients and care partners.